Originally published In Press as doi:10.1074/jbc.M202018200 on March 13, 2002
J. Biol. Chem., Vol. 277, Issue 20, 17789-17796, May 17, 2002
Modification of Late Membrane Permeability in Avian
Reovirus-infected Cells
VIROPORIN ACTIVITY OF THE S1-ENCODED NONSTRUCTURAL p10
PROTEIN*
Gustavo
Bodelón,
Lucía
Labrada
,
José
Martínez-Costas, and
Javier
Benavente§
From the Departamento de Bioquímica y Biología
Molecular, Facultad de Farmacia, Universidad de Santiago de
Compostela, 15782 Santiago de Compostela, Spain
Received for publication, February 28, 2002, and in revised form, March 13, 2002
 |
ABSTRACT |
Infection of chicken embryo fibroblasts by avian
reovirus induces an increase in the permeability of the host plasma
membrane at late, but not early, infection times. The absence of
permeability changes at early infection times, as well as the
dependence of late membrane modification on both viral protein
synthesis and an active exocytic route, suggest that a virus-encoded
membrane protein is required for avian reovirus to permeabilize cells. Further studies revealed that expression of nonstructural p10 protein
in bacterial cells arrested cell growth and enhanced membrane permeability. Membrane leakiness was also observed following transient expression of p10 in BSC-40 monkey cells. Both its permeabilizing effect and the fact that p10 shares several structural and physical characteristics with other membrane-active viral proteins indicate that
p10 is an avian reovirus viroporin. Furthermore, the fusogenic extracellular NH2-terminal domain of p10 appears to
be dispensable for permeabilizing activity, because its deletion
entirely abolished the fusogenic activity of p10, without affecting its
ability to associate with cell membranes and to enhance membrane
permeability. Similar properties have reported previously for
immunodeficiency virus type I transmembrane glycoprotein gp41. Thus,
like gp41, p10 appears to be a multifunctional protein that
plays key roles in virus-host interaction.
 |
INTRODUCTION |
Cytolytic viruses induce profound injurious effects in susceptible
host cells, resulting in morphological, structural, and biochemical
changes and in cell degeneration. A widespread phenomenon during viral
infection is the alteration of the permeability of the host plasma
membrane (reviewed in Refs. 1-3). Viruses can modify the membranes of
their host cells in at least two ways: (i) by promoting membrane fusion
between virus and cell and/or between cell and cell and (ii) by
altering the permeability of the plasma membrane (reviewed in Ref. 4).
The latter can occur at two different stages of infection: either
during virus entry or at late infection times. Early membrane
permeabilization is induced by input virus particles during the process
of virus entry and uncoating, and causes structural and functional
changes in the membrane. The extent and degree of these modifications
vary with the virus-cell system and with the multiplicity of infection. On the other hand, enhanced permeability at late infection times requires virus gene expression and is manifested as a general increase
in permeability to ions and small molecules, but not to macromolecules,
suggesting the formation of hydrophilic pores in the plasma membrane.
Recent evidence suggests that these pores are formed by specific viral
proteins, whose ultimate function is to disorganize the membrane and
kill the infected cell. These membrane-perturbing viral proteins,
termed viroporins, share several physical and structural
characteristics (reviewed in Ref. 1).
Avian reoviruses are members of the Orthoreovirus genus, one of the
nine genera of the Reoviridae family. These agents replicate in the
cytoplasm and contain a genome formed by 10 segments of double-stranded
RNA enclosed within a double protein capsid shell, but lack a lipid
envelope (5, 6). The infection of cultured cells by avian reoviruses
causes strong cytopathic effects, manifested by shrinkage, rounding,
and detachment from the plate. The cytopathic effects of avian reovirus
infection are rather complex, involving syncytia formation and
apoptosis (7, 8).1 Previous
reports have revealed that the syncytia formation activity of avian
reoviruses is associated with genome segment S1 (10), a gene that
contains three partially overlapping, out-of-phase, open reading frames
(ORFs),2 which are highly
conserved in all avian reovirus strains examined to date (Fig. 1). All
three S1 ORFs are expressed in infected cells (11, 12); ORFs 1 and 2 direct the synthesis of the nonstructural proteins p10 and p17, which
associate with cell membranes, whereas distal ORF3 expresses protein
C, a minor trimeric structural protein that is involved in virus
attachment to cell receptors (13, 14). Recent evidence indicates that
there is a close association between nonstructural p10 protein and the
syncytial phenotype displayed by avian reoviruses (11, 15). This
protein is a small transmembrane type-I (N-out) protein, and mutagenic analysis revealed that a region of its extracellular
NH2-terminal domain displays a
sequence-dependent effect on the fusogenic activity of p10
(Ref. 15 and Fig. 1).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 1.
Structure of the S1 genome segment and of the
p10 protein of avian reovirus S1133. A, schematic
representation of the ORF distribution of the tricistronic S1133 S1
gene. The positions of the start and stop codons are indicated at the
ends of the corresponding ORFs. The name, number of amino
acid residues, and molecular mass of the proteins encoded by each ORF
are indicated within boxes. B, amino acid
sequences of p10 protein and of a deleted version of p10 lacking its
first 22 NH2-terminal amino acid residues (p10*). The
predicted transmembrane, extracellular, and intracellular domains of
these proteins are indicated within boxes in the middle of
the two sequences. Basic amino acids located in the intracellular
region adjacent to the transmembrane domain are dotted and
cysteine residues marked with an asterisk.
|
|
In this study we have investigated the capability of avian reovirus to
alter the permeability of the host plasma membrane. We found that
infection of chicken embryo fibroblasts (CEF) by avian reovirus S1133
causes membrane leakiness at late infection times, and that this
alteration is dependent on both viral protein synthesis and protein
translocation through the vesicular system. We also found that
expression of avian reovirus nonstructural p10 protein in both
prokaryotic and eukaryotic cells induces destabilization of the cell
membrane, and that this function is not abolished by deletion of its
extracellular fusogenic domain.
 |
EXPERIMENTAL PROCEDURES |
Cells, Viruses, Antibodies, and Cloning--
Primary cultures of
CEF were prepared from 9-10-day-old chicken embryos and grown in
medium 199 supplemented with 10% tryptose phosphate broth and 5% calf
serum. Monkey BSC-40 cells were grown in monolayers in medium 199 supplemented with 10% fetal bovine serum. Strain S1133 of avian
reovirus was grown in semiconfluent monolayers of primary CEF, as
described previously (16).
Preparation of polyclonal antibodies against the three S1-encoded avian
reovirus proteins has been described previously (11). Rabbit polyclonal
antibodies against the purified nonstructural protein µNS were raised
in our laboratory.
Cloning of ORF1 into prokaryotic and eukaryotic expression
vectors has also been described (11). To generate ORF1*, ORF2, and ORF3
DNA inserts, the recombinant plasmid pBsct-S1 (11) was subjected to PCR
amplification with the following primers. For ORF1*, the forward primer
was 5'-CGGAATTCACGATGGCTCAGAACACGGCAGGT-3' (EcoRI site underlined) and the reverse primer was
5'-CCCGTCGACTCAAACGTCGTATGGCGGAG-3' (SalI site
underlined). For ORF2, the forward primer was
5'-CGGAATTCGTAAGCGCAATGGAATGGCTC-3' (EcoRI site
underlined) and the reverse primer was
5'-CCCGTCGACTCATAGATCGGCGTCAAATCG-3' (SalI site
underlined). For ORF3, the forward primer was
5'-CGGAATTCTTCATTGGGATGGCGGG-3' (EcoRI site
underlined) and the reverse primer was
5'-CCCGTCGACTTAGGTGTCGATGCCGGTAC-3' (SalI site
underlined). Forward primers were designed to contain an initiation AUG
codon with a strong context for translation initiation (17). The
resulting amplification products were digested and cloned into
EcoRI and SalI sites of expression vectors pMalC and pCIneo. The correct orientation of the inserts was confirmed by
nucleotide sequencing of the recombinant plasmids.
Induction of Recombinant Protein Expression in Escherichia
coli--
Overnight cultures of either BL21(DE3) or BL21(DE3)pLysE
cells containing the indicated plasmid, grown at 37 °C in LB medium, supplemented either with 0.2% glucose and 100 µg/ml ampicillin for
BL21(DE3) cells or with 0.2% glucose, 100 µg/ml ampicillin, and 34 µg/ml chloramphenicol for BL21(DE3)pLysE cells, were diluted 100-fold
in the same supplemented medium. When an absorbance of 0.6 at 600 nm
was reached, cultures were induced by the addition of 1 mM
isopropyl-1-thio-
-D-galactopyranoside (IPTG).
Viral Infections, Transfections, Metabolic Radiolabeling, and
Electrophoretic Analysis of Proteins--
Infection of CEF by avian
reovirus S1133 and transient expression of viral proteins in BSC-40
cells have been described previously (11). For assessing
permeabilization of eukaryotic cells to hygromycin B (HB) (Calbiochem,
San Diego, CA), the inhibitor was added, at a final concentration of
1.5 mM, to the cultured medium 45 min before the start of
radioactive labeling. For protein radiolabeling, the cultured medium
was supplemented with 100 µCi/ml
[35S]methionine-cysteine (1.45 Ci/mmol, Amersham
Biosciences) and incubated at 37 °C for 45 min. Cells were
washed with phosphate-buffered saline and then lysed in 3× Laemmli
sample buffer (18), and proteins were resolved on a 10% SDS-PAGE gel
and visualized by autoradiography. For metabolic radiolabeling in
bacteria, cells were incubated for 20 min at 37 °C in the presence
of 0.4 mM HB and 70 µCi/ml
[35S]methionine-cysteine. Labeled cells were then
collected and lysed in 3× Laemmli sample buffer.
Estimation of Uridine Release--
Uridine preloading of
cultured cells and subsequent estimation of release were done
essentially as described previously (19, 20). For eukaryotic cells,
14 h before infection or transfection, semiconfluent cell
monolayers were incubated for 14 h at 37 °C in medium
containing 2 µCi/ml [5,6-3H]uridine (32 Ci/mmol,
Amersham Biosciences). The cells were then washed with
phosphate-buffered saline and subjected to either viral infection or
lipofection. At the indicated times, the culture medium was collected,
centrifuged at 8,000 × g for 5 min, and the
supernatant was mixed with scintillation mixture (989, PerkinElmer Life
Sciences). The radioactivity was then quantified in a liquid scintillation counter. For bacterial cells, 90 min before IPTG induction, cultures were incubated for 1 h in medium supplemented with 4 µCi/ml [5,6-3H]uridine. The cells were then
pelleted and washed twice with prewarmed isotope-free culture medium,
resuspended in the initial volume of growth medium, and incubated at
37 °C. After IPTG induction, 0.3-ml aliquots of the culture were
collected and cells were pelleted. Quantification of the radioactivity
in the supernatant was done as above.
Subcellular Fractionation and Immunoblot
Analysis--
Fractionation of transfected BSC-40 cells and Western
blotting analysis were done as described previously (11). Isolation of
bacterial membranes was essentially done as described by Lama and
Carrasco (21) with minor modifications. Briefly, 30 min after IPTG
induction, bacteria were pelleted and washed twice with a buffer
containing 50 mM Tris-HCl, pH 7.6, and 100 mM
NaCl. Cells were finally resuspended in buffer A (50 mM
Tris-HCl, pH 7.6, 100 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, and 5% glycerol) and lysed by
sonication. The resulting extracts were clarified by low speed
centrifugation (2,500 × g for 10 min), and the
supernatant was centrifuged again (100,000 × g for 30 min). The pelleted membrane fraction was resuspended in buffer A, and
proteins in this fraction and in the supernatant fraction were resolved
by SDS-PAGE and subsequently visualized by Coomassie Blue staining.
 |
RESULTS |
Avian Reovirus Causes Membrane Leakiness at Late Infection
Times--
To analyze membrane permeability changes in response to
avian reovirus infection, several assays were performed. First, the ability of HB to cross the membrane of avian reovirus-infected cells
was investigated at different infection times. HB, which does not
normally trespass the membrane barrier of intact cells, does penetrate
cells with permeabilized membranes, causing strong inhibition of
intracellular protein synthesis; it is therefore widely used to study
changes in membrane permeability (1). The results shown in Fig.
2A indicate that, although HB
was unable to cross the plasma membrane of both uninfected CEF (Fig.
2A, compare lanes 1 and 2)
and early-infected CEF (Fig. 2A, lanes 3-6), it readily penetrated S1133-infected CEF at late
infection times, blocking protein synthesis (Fig. 2A,
compare lanes 7 and 8). These results
indicate that viral infection induces enhanced membrane permeability at
late, but not early, infection times. To determine whether the
perturbed plasma membrane also allows increased efflux of compounds, we
next examined the leakage of radioactivity from
[3H]uridine-preloaded cells. As can be observed in Fig.
2B, a substantially greater amount of radioactivity was
released from infected cells at 9 h after infection than at 0 or
2 h after infection. These data clearly illustrate that the plasma
membrane of avian reovirus-infected cells is permeabilized
bidirectionally at late infection times, allowing increased entry and
exit of metabolites.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 2.
Membrane permeability assays.
A, mock-infected (CEF) and avian
reovirus-infected cells (50 pfu/cell; S1133-CEF) were
incubated, at the indicated times after infection, for 45 min in the
presence (even lanes) or absence (odd
lanes) of 1.5 mM HB. Cells were then labeled
with [35S]methionine-cysteine for another 45 min in the
presence of HB. Cell extracts were prepared and analyzed by SDS-PAGE
and autoradiography. Positions of molecular size markers are indicated
on the left, and positions of the three size classes of
avian reovirus polypeptides are indicated on the right.
B, cells were pre-incubated in medium containing 2 µCi/ml
[5,6-3H]uridine for 14 h and then infected. At the
indicated infection times, the radioactivity released to the medium was
measured. The values shown are means of four independent experiments,
and error bars indicate standard deviations of
the mean.
|
|
Membrane Permeabilization by Avian Reovirus Requires Viral Protein
Synthesis and Protein Translocation through the Vesicular
System--
We next performed experiments to assess whether newly
synthesized viral proteins are required for the late permeability
changes induced by avian reovirus. First of all, we checked whether the onset of viral protein synthesis and membrane modification are concurrent, by performing infections at two different multiplicities of
infection (Fig. 3). When cells were
infected with a multiplicity of 5 pfu/cell, viral protein synthesis and
enhanced permeability to HB were both first detected at 9 h after
infection, as shown by 35S-metabolic labeling and
immunoblot analysis of the nonstructural viral protein µNS in
HB-treated and untreated cells (Fig. 3, A and B).
Increasing the multiplicity of infection up to 100 pfu/cell accelerated
both processes; onset of both viral protein synthesis and membrane
leakiness was now detectable at 6 h after infection (Fig. 3,
C and D). The fact that the onsets of these two
events are concurrent suggests a cause-effect relationship.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 3.
Effects of viral multiplicity on viral
protein synthesis and membrane permeability. Cells were infected
with either 5 pfu/ml (panels A and B) or 100 pfu/ml (panels C and D) of avian reovirus S1133
and incubated with (even lanes) or without
(odd lanes) 1.5 mM HB for 45 min, at
the times indicated on top. A and C,
cells were then labeled with [35S]methionine-cysteine for
another 45 min in the presence of the inhibitor, and then lysed. Total
cell extracts were analyzed by SDS-PAGE, with visualization of proteins
by autoradiography. Positions of molecular mass markers are indicated
on the left of panel A, and positions of the
three size classes of avian reovirus polypeptides are indicated
between the two panels. B
and D, nonradiolabeled cell extracts were subjected to
immunoblot analysis with anti-µNS rabbit polyclonal antibodies.
|
|
To confirm this, membrane permeabilization to HB was analyzed in
infected cells cultured in the presence of ribavirin. Ribavirin is a
guanosine nucleoside analog that has been shown to inhibit avian and
mammalian reovirus gene expression, at the level of virus
transcription, without affecting the expression of cellular genes
(22).1 We have shown previously that the presence of
ribavirin in the culture medium of uninfected CEF cells, at
concentrations up to 400 µM, does not affect either the
viability of the cells for at least 3 days or their protein synthesis
capacity, analyzed 16 h after addition of the inhibitor. In the
same study we also showed that ribavirin, when added to avian
reovirus-infected cells at the start of the infection, does not prevent
viral uncoating, indicating that the drug does not affect the capacity
of the avian reovirus to penetrate and uncoat within endosomes. The
results shown in Fig. 4 (A and
B) reveal that ribavirin does not inhibit protein synthesis
in uninfected cells (compare lanes 1 and 2), but
induces a drastic reduction in the synthesis of viral polypeptides, but
not cell polypeptides, in avian reovirus-infected cells (compare lanes 5 and 6). This result demonstrates that
ribavirin is a specific inhibitor of reoviral, but not cellular, gene
expression. Analysis of HB internalization in ribavirin-treated cells
showed that, although ribavirin did not promote the entry of HB into
uninfected cells (Fig. 4A, compare lanes 3 and
4), its presence prevented HB internalization in late-stage
infected cells (Fig. 4A, compare lanes 7 and
8). Likewise, HB internalization did not take place in cells
infected with UV-treated, replication-incompetent reovirions (data not
shown). Together, these results demonstrate that viral gene expression
is required for avian reovirus to permeabilize the host plasma membrane
and also suggest that late membrane leakiness is induced by a
viroporin.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 4.
Effects of ribavirin and brefeldin A on
membrane permeability. Mock-infected cells (CEF) and
avian reovirus-infected cells (S1133-CEF) were incubated for
9 h in the presence (even lanes) or absence
(odd lanes) of 200 µM ribavirin
(Rib.; panels A and B) or 5 µg/ml
brefeldin A (BA; panel C). The culture medium was
then supplemented (lanes +) or not
(lanes ) with 1.5 mM HB and
incubated for another 45 min. A and C, cells were
subsequently labeled with [35S]methionine-cysteine for 45 min and then lysed, and total cell extracts were analyzed by SDS-PAGE
and autoradiography. Positions of molecular mass markers are indicated
on the left of panel A, and positions of the
three size classes of avian reovirus polypeptides are indicated
between the two panels. B,
nonradiolabeled cells were lysed, and the resulting cell extracts were
subjected to immunoblot analysis with rabbit anti-µNS
antiserum.
|
|
Because viroporins are transmembrane proteins that exert their
permeabilizing effect when inserted into the cell membrane, we next
investigated whether an active exocytic route is required for membrane
permeabilization in avian reovirus-infected cells. With this end, we
investigated the effect of brefeldin A on the capacity of HB to
penetrate late-stage infected cells (Fig. 4C). Brefeldin A
is a macrolide antibiotic that has been shown to inhibit vesicle
transport to the cell surface, by causing the resorption of the Golgi
complex into the endoplasmic reticulum (23-25). At the concentration
of 5 µg/ml, brefeldin A did not inhibit protein synthesis in
uninfected CEF (compare lanes 1 and 2) and caused only a minor reduction in protein synthesis in avian reovirus-infected cells (compare lanes 5 and 6). Furthermore, the
presence of brefeldin A only induced a slight decrease in the
intracellular production of infectious viral particles (data not
shown), indicating that this antibiotic hardly affects virus
replication and reovirion assembly. Similar results regarding the
effect of brefeldin A have been reported previously for the replication
of avian reovirus 176 in the continuous quail fibrosarcoma cell line
QT6 (26). However, the presence of brefeldin A abrogated the ability of the virus to induce both membrane permeabilization to HB (Fig. 4C, compare lanes 7 and 8) and
syncytia formation (data not shown), indicating that an active exocytic
system is required for avian reovirus to induce these alterations.
Modification of Membrane Permeability by Avian Reovirus p10
Protein--
We have recently shown that the two nonstructural
proteins, p10 and p17, encoded by the tricistronic avian reovirus S1
gene become associated with cell membranes in both prokaryotic and eukaryotic cells (11). A priori, then, these two
proteins appear to be good candidates for involvement in membrane
permeabilization. To assess the permeabilizing activity of the
S1-encoded proteins, we first used an inducible Escherichia
coli expression system that has been shown to be suitable for the
characterization of other membrane-active viral proteins. In this study
we used E. coli BL21(DE3)pLysE cells, which contain an
IPTG-inducible T7 RNA polymerase gene within the chromosome as well as
the pLysE plasmid that constitutively expresses high levels of the T7
phage lysozyme (27). This system, therefore, allows us to test for permeabilization of the inner bacterial membrane, because, when intact,
intracellular lysozyme cannot reach the cell wall, whereas a perturbed
membrane will allow lysozyme to gain acces to and degrade the cell wall
peptidoglycan, giving rise to rapid cell lysis.
As a first approach to analyzing the effect of the three S1-encoded
proteins on bacterial membranes, their open reading frames were
individually cloned into the maltose-binding protein (MBP) gene fusion
vector, pMalC, and the resulting recombinant plasmids were used to
transform BL21(DE3)pLysE E. coli cells. Electrophoretic analysis of extracts from recombinant bacteria showed that MBP and all
three MBP-fused polypeptides were expressed in IPTG-induced bacteria
(Fig. 5C, odd
lanes), but not in uninduced bacteria (data not shown). The
growth rates of the transformed bacterial cells were analyzed
spectrophotometrically by measurement of optical density at 600 nm. The
results shown in Fig. 5A revealed that, whereas bacteria
transformed with pMalC, pMalC-ORF3, or pMalC-ORF2 grew exponentially
during the 180-min period following IPTG induction, a drastic arrest of
cell growth followed IPTG induction of pMalC-ORF1-transformed bacteria.
This finding indicates that expression of p10 enhances the permeability
of the inner membrane to intracellular lysozyme, giving rise to rapid
cell lysis. On the other hand, the expression of MBP-p10, but not of
the other two MBP-fused proteins, promoted the release of substantial
amounts of radioactivity from [3H]uridine-preloaded cells
(Fig. 5B) and rendered cells susceptible to HB inhibition
(Fig. 5C, compare odd lanes with
even lanes).

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 5.
Effects of the three S1-encoded proteins on
bacterial membrane permeability. E. coli BL21(DE3)pLysE
cells carrying the plasmids indicated within the box were
induced with 1 mM IPTG. A, the optical
densities of cell cultures at 600 nm were measured at the indicated
times after induction. B, cells that had been preloaded with
[5,6-3H]uridine were IPTG-induced and, at the indicated
times after induction, the radioactivity released to the medium was
measured. The values shown are means of four independent experiments.
C, 1 h after induction, cells transformed with pMalC
(lanes 1 and 2) or with one of the pMalC
recombinant plasmids containing the inserts shown on top
(lanes 3-8) were incubated for 20 min with
[35S]methionine-cysteine in the absence (odd
lanes) or presence (even lanes) of 0.4 mM HB. Cells were then lysed, and the extracts analyzed by
SDS-PAGE and autoradiography. Positions of MBP and of MBP-fused
proteins are indicated on the sides of the figure.
|
|
To gather more evidence on the permeabilization activity of p10, we
next compared the capacity of p10 and p17 to induce membrane leakiness
in eukaryotic cells. First of all, the p17- and p10-encoding ORFs were
individually cloned into the eukaryotic expression vector pCIneo, and
the resulting recombinant plasmids were lipofected into monolayers of
BSC-40 monkey cells. The Western blot analysis shown in Fig.
6 (A and B)
demonstrates that the two proteins were synthesized in transfected
cells, as previously reported (11). A subsequent electrophoretic
analysis of 35S-radiolabeled cell extracts revealed that,
although HB could readily penetrate cells transformed with pCIneo-ORF1
(Fig. 6C, lane 3), this inhibitor was unable to
cross the plasma membrane of cells lipofected with either the empty
vector or the pCIneo-ORF2 recombinant vector (Fig. 6C,
lanes 1 and 2). Furthermore, the amount of
radioactivity released from [3H]uridine-preloaded cells
was much greater in pCIneo-ORF1-transformed cells than in cells
lipofected with either pCineo or pCIneo-ORF2 (Fig. 6D).
These data demonstrate that p10, but not p17, possesses permeabilizing
activity in both eukaryotic and prokaryotic cells.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 6.
Permeabilization activity of p10 and p17
expressed in eukaryotic cells. Semiconfluent monolayers of BSC-40
cells were lipofected with the recombinant expression vectors pCIneo,
pCIneo-ORF1, or pCIneo-ORF2 and then incubated for 20 h.
A and B, cells were then lysed and subjected to
immunoblot analysis with polyclonal antibodies raised against the
recombinant proteins MBP-p10 (panel A) and His-p17
(panel B). C, cells were then incubated for 45 min in the presence of 1.5 mM HB, and for another 45 min in
the presence [35S]methionine-cysteine. Total cell
extracts were then prepared and analyzed by SDS-PAGE and
autoradiography. Positions of molecular mass markers are indicated on
the left. D, the radioactivity released to the
medium from [5,6-3H]uridine-preloaded cells was measured.
The values shown are means of four independent experiments, and
error bars indicate standard deviations of the
mean.
|
|
The Fusogenic Domain of p10 Is Dispensable for Its Membrane
Permeabilizing Activity--
It has been recently shown that p10 is a
type I transmembrane protein that causes cell-cell fusion when
transiently expressed in mammalian cells, and that deletion of a region
of its extracellular NH2-terminal domain abrogates the
fusogenic activity of p10, without affecting its ability to associate
with cell membranes (15). As a first approach to assessing whether this
"fusogenic sequence" is also involved in membrane permeabilization,
a 5'-truncated version of the ORF1 (ORF1*) was cloned into the
prokaryotic expression vector pMalC or the eukaryotic vector pCIneo.
The resulting recombinant vectors pMalC-ORF1* and pCIneo-ORF1*, as well
as their corresponding empty vectors and the recombinant vectors
containing nontruncated ORF1 inserts, were then introduced into
prokaryotic or eukaryotic cells.
The experiments carried out with bacterial cells are shown in Fig.
7. Both electrophoretic and immunoblot
analysis of cell extracts demonstrated that MBP, MBP-p10, and MBP-p10*
were all expressed in the corresponding transformed bacteria after IPTG induction (Fig. 7, A and B, lanes 2,
6, and 10), but not in uninduced bacteria
(lanes 1, 5, and 9). Fractionation of
the extracts from induced bacteria (I) into supernatant
(S) and pellet (P) fractions revealed that,
whereas most MBP is associated with the soluble fraction (Fig. 7,
A and B, compare lanes 3 and
4), both MBP-p10 and MBP-p10* segregated almost exclusively
with the pelleted fraction (Fig. 7, A and B,
compare lanes 7 and 11 with lanes 8 and 12), suggesting that they become associated with the
bacterial membrane. Furthermore, IPTG induction of bacteria transformed
with pMalC-ORF1 and with pMalC-ORF1*, but not with the empty plasmid
pMalC, caused arrest of cell growth (Fig. 7C), suggesting
that both p10 and p10* facilitate access of the intracellular lysozyme
to the cell wall, by permeabilizing the inner membrane. Finally, both
HB internalization and leakage of radioactivity from
[3H]uridine-preloaded bacteria were observed in cells
transformed with the two recombinant plasmids, but not in cells
transformed with the empty plasmid pMalC (Fig. 7, D and
E). From these results, we conclude that both p10 and p10*
have the ability to permeabilize bacterial membranes.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 7.
Permeability changes induced by expression of
p10 and p10* in bacterial cells. A and B,
overnight cultures of E. coli BL21(DE3) cells carrying the
plasmids pMalC ( ), pMalC-ORF1 (ORF1), or
pMalC-ORF1* (ORF1*) were induced with IPTG (lanes
I) or not (lanes U), and 30 min later
cells were lysed and the extracts fractionated into supernatant
(S) and pellet (P) fractions by centrifugation.
Samples were then analyzed by SDS-PAGE, and proteins were either
visualized by Coomassie Blue staining (panel A) or
transferred to a polyvinylidene difluoride membrane and subjected to
immunoblot analysis with a polyclonal anti-MBP antiserum (panel
B). C, the optical densities at 600 nm of cultures of
E. coli BL21(DE3)pLysE transformed with the plasmids
indicated within the box were measured at the indicated
times after induction. Values shown are means of three independent
experiments. D, 1 h after induction, transformed
E. coli BL21(DE3)pLysE cells were incubated for 20 min with
[35S]methionine-cysteine in the presence (even
lanes) or absence (odd lanes) of 0.4 mM HB. Cells were then lysed, and the extracts analyzed by
SDS-PAGE and autoradiography. Positions of MBP-p10 and of MBP-p10* are
indicated on the right. E, transformed E. coli BL21(DE3)pLysE cells that had been preloaded with
[5,6-3H]uridine were induced with IPTG and the
radioactivity released to the medium was measured at the indicated
times after induction. Values shown are means of three independent
experiments.
|
|
A similar conclusion was reached from the results of the experiments
performed with eukaryotic cells (Fig. 8).
Thus, whereas p17, p10, and p10*, but not
C, segregate exclusively
with the membrane fraction when transiently expressed in BSC-40 monkey cells (Fig. 8A), only p10 and p10* are able to promote both
HB internalization and uridine release (Fig. 8, B and
C). Taken together, these results demonstrate that the
fusogenic amino-terminal fragment of p10 is dispensable for membrane
association and for membrane permeabilization. However, this fragment
is indeed required for the fusogenic activity of p10, because its
deletion abrogated the syncytia formation capacity of p10 (Fig.
8D), as reported previously (15).

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 8.
Permeabilization and fusogenic activities of
p10 and p10* expressed in eukaryotic cells. A,
immunoblot analysis of soluble (S) and membrane
(M) fractions prepared from extracts of BSC-40 cells
lipofected with pCIneo-ORF3 ( C), pCIneo-ORF2
(p17), pCIneo-ORF1 (p10), or pCIneo-ORF1*
(p10*). Protein C was detected with anti- C, protein
p17 with anti-His-p17, and proteins p10 and p10* with anti-MBP-p10
polyclonal antiserum. B, at 20 h after transfection,
lipofected cells were incubated for 45 min with 1.5 mM HB,
and for another 45 min in the presence of
[35S]methionine-cysteine. Cells were then lysed, and
total cell extracts were analyzed by SDS-PAGE and autoradiography.
Positions of molecular mass markers are indicated on the
left. C, cells that had been lipofected with the
plasmids shown on top were visualized at 36 h after
transfection by microscopy under visible light after staining with
Giemsa. Lanes , cells were mock-transfected
with Lipofectin.
|
|
 |
DISCUSSION |
The alteration of membrane permeability is a common feature of
infection by cytolytic animal viruses, and such alterations not only
exert profound effects on the metabolism of the infected cell, they
also contribute to the development of the cytopathic effect. Early
alterations of the membrane allow low molecular weight compounds as
well as macromolecules to enter cells together with viral particles.
Late membrane leakiness requires virus gene expression and allows the
passage of ions and small molecules, but not macromolecules (reviewed
in Ref. 1).
In the first part of the present study, we examined host membrane
alterations in response to avian reovirus infection. We found that the
plasma membrane of S1133-infected CEF becomes permeabilized at late,
but not early, infection times, and that the perturbed membrane allows
increased influx and efflux of metabolites. Enhanced membrane
permeability at late infection times has been also observed in cells
infected with flaviviruses (28), herpesviruses, rhabdoviruses (29),
paramyxoviruses (29), papovaviruses (30), picornaviruses (31),
retroviruses (32, 33), and togaviruses (34).
The absence of increased permeability at early infection times, and the
dependence of membrane leakiness on both virus gene expression and
intracellular protein trafficking, strongly suggest that viroporins are
involved in avian reovirus-induced permeabilization. Accordingly, in
the second part of our study, we tried to identify avian reovirus
proteins displaying viroporin activity. We focused on the proteins
encoded by the tricistronic S1 genome segment because two of them, the
nonstructural proteins p10 and p17, have been shown recently to
associate with the membranes of both prokaryotic and eukaryotic cells
(11), and also because p10 has been shown both to display fusogenic
activity (11, 15) and to share structural characteristics with other
membrane-active viral proteins (see below). Our results demonstrate
that, although both nonstructural proteins p10 and p17, but not
C,
are entirely associated with prokaryotic and eukaryotic cell membranes,
only the expression of p10 is able to induce enhanced membrane
permeability to HB and uridine. Furthermore, p10, but not p17 or
C,
inhibited cell growth in the E. coli system, suggesting that
p10 induces disorganization of the inner bacterial membrane and hence
allows cytoplasmic lysozyme to reach and digest the peptidoglycan layer
of the outer cell wall. Taken together, these results indicate that p10
is an avian reovirus viroporin, and also strongly suggest that p10 is
the protein involved in modifying membrane permeability in avian
reovirus-infected cells. In support of this possibility, we found that
the onsets of membrane permeabilization to HB and p10 synthesis, in
cells infected with different avian reovirus multiplicities, were
concurrent (data not shown). Several proteins from different viruses
have also been reported to possess viroporin activity, including
poliovirus 2BC and 3AB (19, 21, 35); adenovirus E3-11.6K (36);
togavirus 6K (37); coxsackie B3 virus 2B (38); hepatitis C virus E1 (39); influenza M2 (40); picornavirus 3A and 2B (41); hepatitis A virus
3A, 2B, and 2BC (42, 43); human immunodeficiency virus type-1 gp41 and
Vpu (32, 33); rotavirus NSP4 (44); African horse sickness virus NSP3
(45); human respiratory syncytial virus small hydrophobic protein (20);
and small hydrophobic nonstructural proteins of Japanese encephalitis
virus (28).
In contrast to most nonenveloped viruses, including mammalian
reoviruses, avian reoviruses induce syncytia formation, an activity related to the nonstructural p10 protein. Furthermore, this fusion activity appears to be located at the extracellular amino terminus of
p10, because deletion of its extreme NH2-terminal fragment abrogates the ability of p10 to cause cell-cell fusion, without affecting its capacity to associate with membranes (15). Therefore, it
was important to assess the implication of this fragment in the
permeabilizing activity of p10. The results of the present work
indicate that the fragment containing the initial
NH2-terminal 22 amino acid residues of p10, although
necessary for fusogenic activity, is not required for membrane
permeabilization, because its deletion does not affect the capacity of
p10 to associate with cell membranes or to trigger permeability changes
in either prokaryotic or eukaryotic cells. This finding suggests that
syncytium formation and membrane destabilization are associated with
different domains of the p10 protein and, therefore, that they are
unrelated phenomena. Furthermore, these two events are not concurrent,
because membrane permeabilization always precedes syncytia formation in infected and transfected cells (data not shown). This situation resembles that of the immunodeficiency virus type 1 transmembrane glycoprotein gp41, which contains an amino-terminal domain involved in
membrane fusion and syncytia formation, whereas both the
membrane-spanning region and sequences located at the carboxyl terminus
are involved in increasing membrane permeability (32).
In addition to its permeabilizing activity, p10 also shares several
structural and physical characteristics with other viroporins. Thus,
p10 and all reported viroporins are small hydrophobic integral membrane
proteins of 50-120 amino acid residues, containing at least one
transmembrane hydrophobic domain of 20-30 residues and an
intracellular region rich in basic residues that is adjacent to the
transmembrane domain (reviewed in Ref. 1). Furthermore, p10 and some
viroporins contain cysteine residues in their cytoplasmic regions,
often positioned proximal to their membrane-spanning domains, and
several of these cysteine residues have been found to be modified by
palmitoylation (46-50). Interestingly, mutagenesis of the two
contiguous cysteines 63 and 64 to alanines, and of lysine 69 to
methionine, was reported to abolish the capacity of avian reovirus
p10 protein to induce syncytia formation but not to associate with
membranes (15). Finally, most viroporins have been shown to form
hydrophilic pores by oligomerization, thus allowing ions and low
molecular weight hydrophilic compounds to diffuse through the membrane
(reviewed in Ref. 1). Whether p10 likewise oligomerizes, whether the
two contiguous cysteines are palmitoylated, and whether these cysteines
and/or the basic residues play a role in the permeabilizing activity of
p10 merit further studies.
The hydrophilic channels formed by viroporin activity allow low
molecular weight hydrophilic molecules to cross the membrane; hence,
membrane potential is disrupted, ionic gradients collapse, and
essential compounds are released from the cell (1, 2, 51). The
alterations in ion concentration occurring in the cytoplasm of
virus-infected cells could favor virus replication, by enhancing the
intracellular concentration of sodium ions. This might promote translation of viral versus cellular mRNAs, because
translation of mRNAs from many cytolytic animal viruses, including
reoviruses, is fairly resistant to high sodium concentrations, whereas
high sodium concentrations are inhibitory for the translation of most cellular mRNAs (52-57). On the other hand, progressive membrane damage is thought to promote cell lysis and virus release, facilitating virus spreading to surrounding cells (9, 36). Curiously, our results
and those of Duncan et al. (26) demonstrate that membrane
permeabilization and syncytia formation are not essential steps in the
avian reovirus replication cycle, because their inhibition by brefeldin
A was not accompanied by a significant reduction in either viral
protein synthesis or infectious progeny virus production. However, the
presence of brefeldin A retards and partially inhibits avian
reovirus-induced cytopathic effects and virus release (26), suggesting
that membrane permeabilization and syncytia formation, although not
strictly required, can accelerate the production of a lytic-type
infection. This, in addition to the fact that both the p10 ORF and the
syncytial phenotype are conserved among all known avian reovirus
isolates as well as two atypical mammalian reoviruses, Nelson Bay virus
and baboon reovirus, suggests that expression of the p10 protein could
confer some selective advantages to the virus, such as enhanced virus
spreading in infected animals. Assessing the role that the p10 protein
plays in the replication cycle of avian reovirus is problematic,
because no method has yet been developed to manipulate the reoviral
genome to generate mutant viruses that do not express a particular
protein or that express mutated proteins.
 |
ACKNOWLEDGEMENTS |
We are grateful to Laboratorios Intervet
(Salamanca, Spain) for providing the specific-pathogen-free embryonated
eggs. We thank Luis Carrasco and Rubén Varela for critical
reading of the manuscript and José Antonio Trillo for providing
technical support and assistance.
 |
FOOTNOTES |
*
This work was supported by Spanish Ministry of Science and
Technology Grant PB97-0523.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Dept. of Medicine, Columbia University College of
Physicians and Surgeons, New York, NY 10032.
§
To whom correspondence should be addressed. Tel./Fax:
34-981-599157; E-mail: bnjbena@usc.es.
Published, JBC Papers in Press, March 13, 2002, DOI 10.1074/jbc.M202018200
1
L. Labrada, G. Bodelón, J. Viñuela,
and J. Benavente, submitted for publication.
 |
ABBREVIATIONS |
The abbreviations used are:
ORF, open reading
frame;
CEF, chicken embryo fibroblast;
HB, hygromycin B;
IPTG, isopropyl-1-thio-
-D-galactopyranoside;
pfu, plaque-forming unit;
MBP, maltose-binding
protein.
 |
REFERENCES |
| 1.
|
Carrasco, L.
(1995)
Adv. Virus Res.
45,
61-112[Medline]
[Order article via Infotrieve]
|
| 2.
|
Carrasco, L.,
Otero, M. J.,
and Castrillo, J. L.
(1989)
Pharmacol. Ther.
40,
171-212[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Carrasco, L.,
Perez, L.,
Irurzun, A,
Lama, J.,
Martinez-Abarca, F.,
Rodriguez, P.,
Guinea, R.,
Castrillo, J. L.,
Sanz, M. A.,
and Ayala, M. J.
(1993)
in
Regulation of Gene Expression in Animal Viruses
(Carrasco, L.
, Sonemberg, N.
, and Wimmer, E., eds)
, pp. 283-305, Plenum Publishing Corp., New York
|
| 4.
|
Knipe, D. M.
(1996)
in
Virus-Host Cell Interactions: Fields Virology
(Fields, B. N.
, Knipe, D. M.
, and Howley, P. M., eds)
, pp. 273-299, Lippincott-Raven, Philadelphia
|
| 5.
|
Nibert, M. L.,
Margraf, R. L.,
and Coombs, K. M.
(1996)
J. Virol.
70,
7295-7300[Abstract/Free Full Text]
|
| 6.
|
Robertson, M. D.,
and Wilcox, G. E.
(1986)
Vet. Bull.
56,
759-766
|
| 7.
|
Duncan, R.,
Murphy, F. A.,
and Mirkovic, R. R.
(1995)
Virology
212,
752-756[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Gard, G.,
and Compans, R. W.
(1970)
J. Virol.
6,
100-106[Abstract/Free Full Text]
|
| 9.
|
Tiganos, E.,
Friborg, J.,
Allain, B.,
Daniel, N. G.,
Yao, X. J.,
and Cohen, E. A.
(1998)
Virology
251,
96-107[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Duncan, R.,
and Sullivan, K.
(1998)
Virology
250,
263-272[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Bodelon, G.,
Labrada, L.,
Martinez-Costas, J.,
and Benavente, J.
(2001)
Virology
290,
181-191[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Shmulevitz, M.,
Yameen, Z.,
Dawe, S.,
Shou, J.,
O'Hara, D.,
Holmes, I.,
and Duncan, R.
(2002)
J. Virol.
76,
609-618[Abstract/Free Full Text]
|
| 13.
|
Martinez-Costas, J.,
Grande, A.,
Varela, R.,
Garcia-Martinez, C.,
and Benavente, J.
(1997)
J. Virol.
71,
59-64[Abstract]
|
| 14.
|
Grande, A.,
Rodriguez, E.,
Costas, C.,
Everitt, E.,
and Benavente, J.
(2000)
Virology
274,
367-377[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Shmulevitz, M.,
and Duncan, R.
(2000)
EMBO J.
19,
902-912[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Grande, A.,
and Benavente, J.
(2000)
J. Virol. Methods
85,
43-54[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Kozak, M.
(1987)
Nucleic Acids Res.
15,
8125-8148[Abstract/Free Full Text]
|
| 18.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Aldabe, R.,
Barco, A.,
and Carrasco, L.
(1996)
J. Biol. Chem.
271,
23134-23137[Abstract/Free Full Text]
|
| 20.
|
Pérez, M.,
Garcia-Barreno, B.,
Melero, J. A.,
Carrasco, L.,
and Guinea, R.
(1997)
Virology
235,
342-351[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Lama, J.,
and Carrasco, L.
(1995)
FEBS Lett.
367,
5-11[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Rankin, J. T. Jr.,
Eppes, S. B.,
Antczak, J. B.,
and Joklik, W. K.
(1989)
Virology
168,
147-158[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Doms, R. W.,
Russ, G.,
and Yewdell, J. W.
(1989)
J. Cell Biol.
109,
61-72[Abstract/Free Full Text]
|
| 24.
|
Miller, S. G.,
Carnell, L.,
and Moore, H. H.
(1992)
J. Cell Biol.
118,
267-283[Abstract/Free Full Text]
|
| 25.
|
Pelham, H. R.
(1991)
Cell
67,
449-451[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Duncan, R.,
Chen, Z.,
Walsh, S.,
and Wu, S.
(1996)
Virology
224,
453-464[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Studier, F. W.,
Rosenberg, A.,
Dunn, J.,
and Dubendorff, J. W.
(1990)
Methods Enzimol.
185,
60-89
|
| 28.
|
Chang, Y. S.,
Liao, C. L.,
Tsao, C. H.,
Chen, M. C.,
Liu, C. I.,
Chen, L. K.,
and Lin, Y. L.
(1999)
J. Virol.
73,
6257-6264[Abstract/Free Full Text]
|
| 29.
|
Benedetto, A.,
Rossi, G. B.,
Amici, C.,
Belardelli, F.,
Cioe, L.,
Carruba, G.,
and Carrasco, L.
(1980)
Virology
106,
123-132[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Contreras, A.,
and Carrasco, L.
(1979)
J. Virol.
29,
114-122[Abstract/Free Full Text]
|
| 31.
|
Carrasco, L.
(1978)
Nature
272,
694-699[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Arroyo, J.,
Boceta, M.,
Gonzalez, M. E.,
Michel, M.,
and Carrasco, L.
(1995)
J. Virol.
69,
4095-4102[Abstract]
|
| 33.
|
Gonzalez, M. E.,
and Carrasco, L.
(1998)
Biochemistry
37,
13710-13719[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Lacal, J. C.,
Vazquez, D.,
Fernandez-Sousa, J. M.,
and Carrasco, L.
(1980)
J. Antibiot.
33,
441-446[Medline]
[Order article via Infotrieve]
|
| 35.
|
Lama, J.,
and Carrasco, L.
(1992)
Biochem. Biophys. Res. Commun.
188,
972-981[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Tollefson, A. E.,
Scaria, A.,
Hermiston, T. W.,
Ryerse, J. S.,
Wold, L. J.,
and Wold, W. S.
(1996)
J. Virol.
70,
2296-2306[Abstract]
|
| 37.
|
Sanz, M. A.,
Perez, L.,
and Carrasco, L.
(1994)
J. Biol. Chem.
269,
12106-12110[Abstract/Free Full Text]
|
| 38.
|
van Kuppeveld, F. J.,
Melchers, W. J.,
Kirkegaard, K.,
and Doedens, J. R.
(1997)
Virology
227,
111-118[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Ciccaglione, A. R.,
Marcantonio, C.,
Costantino, A.,
Equestre, M.,
Geraci, A.,
and Rapicetta, M.
(1998)
Virology
250,
1-8[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Guinea, R.,
and Carrasco, L.
(1994)
FEBS Lett.
343,
242-246[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Doedens, J. R.,
and Kirkegaard, K.
(1995)
EMBO J.
14,
894-907[Medline]
[Order article via Infotrieve]
|
| 42.
|
Pisani, G.,
Beneduce, F.,
Gauss-Muller, V.,
and Morace, G.
(1995)
Biochem. Biophys. Res. Commun.
211,
627-638[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Jecht, M.,
Probst, C.,
and Gauss-Muller, V.
(1998)
Virology
252,
218-227[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Browne, E. P.,
Bellamy, A. R.,
and Taylor, J. A.
(2000)
J. Gen. Virol.
81,
1955-1959[Abstract/Free Full Text]
|
| 45.
|
van Niekerk, M.,
Smit, C. C.,
Fick, W. C.,
van Staden, V.,
and Huismans, H.
(2001)
Virology
279,
499-508[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Hausmann, J.,
Ortmann, D.,
Witt, E.,
Veit, M.,
and Seidel, W.
(1998)
Virology
244,
343-351[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Caballero, M.,
Carabaña, J.,
Ortego, J.,
Fernández-Muñoz, R.,
and Celma, M. L.
(1998)
J. Virol.
72,
8198-8204[Abstract/Free Full Text]
|
| 48.
|
Gaedigk-Nitschko, K.,
Ding, M. X.,
Levy, M. A.,
and Schlesinger, M. J.
(1990)
Virology
175,
282-291[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Castrucci, M. R.,
Hughes, M.,
Calzoletti, L.,
Donatelli, I.,
Wells, K.,
Takada, A.,
and Kawaoka, Y.
(1997)
Virology
238,
128-134[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Yang, C.,
Spies, C. P.,
and Compans, R. W.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
9871-9875[Abstract/Free Full Text]
|
| 51.
|
Fuchs, P.,
and Kohn, A.
(1983)
Curr. Top. Microbiol. Immunol.
102,
57-99[Medline]
[Order article via Infotrieve]
|
| 52.
|
Carrasco, L.,
and Smith, A. E.
(1976)
Nature
264,
807-809[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Castrillo, J. L.,
Lopez-Rivas, A.,
and Carrasco, L.
(1987)
J. Gen. Virol.
68,
325-333[Abstract/Free Full Text]
|
| 54.
|
Macejak, D. G.,
and Sarnow, P.
(1991)
Nature
353,
90-94[Medline]
[Order article via Infotrieve]
|
| 55.
|
Munoz, A.,
Alonso, M. A.,
and Carrasco, L.
(1984)
Virology
137,
150-159[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Nuss, D. L.,
Oppermann, H.,
and Koch, G.
(1975)
Proc. Natl. Acad. Sci. U. S. A.
72,
1258-1262[Abstract/Free Full Text]
|
| 57.
|
Nair, C. N.
(1984)
J. Gen. Virol.
65,
1135-1138[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Torres, U. Maheswari, K. Parthasarathy, L. Ng, D. X. Liu, and X. Gong
Conductance and amantadine binding of a pore formed by a lysine-flanked transmembrane domain of SARS coronavirus envelope protein
Protein Sci.,
September 1, 2007;
16(9):
2065 - 2071.
[Abstract]
[Full Text]
|